ニュース
Ustekinumab may be more effective than anti-tumor necrosis factor (anti-TNF) therapies in achieving clinical remission among patients with Crohn-like disease of the pouch (CLDP), according to study ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
There was an increase in use of neuraxial anesthesia and peripheral nerve block analgesia rather than general anesthesia for hip fracture procedures.
The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health ...
From 2016 to 2022, 5.3% of all US emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same time period.
Associations between neighborhood characteristics (e.g. air pollution and neighborhood socioeconomic status) and mental health outcomes varied by age.
There was an overall decrease in influenza vaccine uptake among US adults from 2020 to 2024, according to a study published online.
A new IVF technique helped 8 babies in the UK avoid serious inherited diseases, and scientists are calling it a breakthrough.
Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.
The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...
Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.
Hydroxychloroquine exposure during the first trimester of pregnancy was associated with a lower risk for preeclampsia among women with SLE.
現在アクセス不可の可能性がある結果が表示されています。
アクセス不可の結果を非表示にする